University of California San Francisco
Give to UCSFUCSF researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain.
A UCSF study of human and mouse pancreatic tissue suggests a new origin story for type 1 diabetes.
Ronald D. Vale, PhD, professor of cellular and molecular pharmacology at UCSF, has been named executive director of the Janelia Research Campus of the Howard Hughes Medical Institute and an HHMI vice president, effective in early 2020.
A program offering group support, acupuncture, mindfulness, massage and gentle exercise may help prevent patients on prescription opioids from spiraling down to drug misuse, overdose and death.
The gift established the endowed Jere E. Goyan Presidential Chair for the Advancement of Pharmacy, which honors the longest-serving dean of the School of Pharmacy.
UCSF scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system.
The Health Innovation Via Engineering program will be led by Tejal Desai.
A personal survey of patients with AF has found that the majority of triggers for the condition are easily modifiable lifestyle choices, including alcohol, caffeine, exercise and lack of sleep.
UCSF Fresno recently received contributions of more than $1 million from two development companies and families known for giving back to the local community.
UCSF researchers created a chimpanzee brain “organoids” that mimic the development and organization of full-size brains.
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.